Saroja Pharma Indus Ind L — Quarterly Results & Earnings

₹28.00

+0.00%

Profit Growth YoY67.65%Latest quarter

Sales Growth YoY106.28%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+67.65%

🔥 Exceptional growth

YoY Sales Growth+106.28%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

4.84%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

2.42

ROE

6.79%

ROCE

12.57%

💡

Growth Analysis

Saroja Pharma Indus Ind L reported YoY profit growth of 67.65% and revenue growth of 106.28% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Saroja Pharma Indus Ind L

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Specialty Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.